References
- World Health Organization. Immunization; [accessed 2020 Dec 24]. https://www.who.int/news-room/facts-in-pictures/detail/immunization
- The State Council of the People’s Republic of China. The regulations on vaccine circulation and vaccination management; 2005 [accessed 2020 Dec 30]. http://www.gov.cn/zhengce/content/2008-03/28/content_6250.htm
- Yuan P, Jin Y, Zheng J, Cao L, Cao L, Cui J, Xiao Q, Xiao H. Surveillance of category II vaccines in China, 2014. Chin J Vaccines Immunization. 2016;22:1–9.
- Wang W, Wang H. Status and influencing factors of vaccination with non-expanded program on immunization vaccines in China. Chin J Vaccines Immunization. 2020;26:93–9.
- Shende P, Waghchaure M. Combined vaccines for prophylaxis of infectious conditions. Artif Cells, Nanomed Biotechnol. 2019;47(1):695–704. doi:10.1080/21691401.2019.1576709.
- David S, Barbara B, Manmohan S, Derek OH. Combination vaccines. J Glob Infect Dis. 2011;3(1):63. doi:10.4103/0974-777X.77298.
- Cui F. Consideration on the vaccination strategy of combined vaccine for children in China. Chin J Viral Dis. 2019;9:161–166. doi:10.16505/j.2095-0136.2019.0037.
- Cui J, Cao L, Zheng J, Cao L, Yuan P, Wang M, Xiao Q, Wang H. Analysis of reported coverage rates of vaccines in national immunization program in China. Chin J Vaccines Immunization. 2016;22:33–40.
- World Health Organization. Haemophilus influenzae type b (Hib) vaccination position paper; 2013 [accessed 2021 Jan 8]. https://www.who.int/wer/2013/wer8839.pdf?ua=1
- World Health Organization. Global literature review of Haemophilus influenzae type b and Streptococcus pneumoniae invasive disease among children less than 5 years of age 1980-2005; 2009 [accessed 2021 Jan 11]. http://whqlibdoc.who.int/hq/2009/WHO_IVB_09.02_eng.pdf
- World Health Organization. WHO position paper on Haemophilus influenzae type b conjugate vaccines; 2006 [accessed 2021 Jan 14]. https://www.who.int/wer/2006/wer8147.pdf?ua=1
- Yu H, Yang W, Varma JK. To save children’s lives, China should adopt an initiative to speed introduction of pneumonia vaccines. Health Aff. 2012;31(11):2545–2553. doi:10.1377/hlthaff.2011.1272.
- Jackson C, Mann A, Mangtani P, Fine P. Effectiveness of Haemophilus influenzae type b vaccines administered according to various schedules: systematic review and meta-analysis of observational data. Pediatr Infect Dis J. 2013;32:1261–1269. doi: http://doi.org/10.1097/INF.0b013e3182a14e57.
- Low N, Redmond SM, Rutjes AWS, Martínes-González NA, Egger M, Md N, Scott P. Comparing Haemophilus influenzae type b conjugate vaccine schedules: a systematic review and meta-analysis of vaccine trials. Pediatr Infect Dis J. 2013;32(11):1245–1256. doi:10.1097/INF.0b013e31829f0a7e.
- World Health Organization. Grading of scientific evidence –table 1: clinical effectiveness of Hib vaccine against Hib invasive disease; [accessed 2021 Jan 15]. https://www.who.int/immunization/position_papers/Hib_effectiveness.pdf
- Watt JP, Wolfson L, O’-Brien KL, Henkle E, Deloria-Knoll M, McCall N, Lee E, Levine OS, Hajjeh R, Mulholland K. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet. 2009;374(9693):903–911. doi:10.1016/S0140-6736(09)61203-4.
- World Health Organization. WHO-UNICEF estimates of Hib3 coverage; 2020 [accessed 2021 July 26]. https://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragehib3.html
- International Vaccine Access Center. Johns Hopkins Bloomberg school of public health. View-hub-Hib vaccine; 2021 [accessed 2021 Sep 8]. https://view-hub.org/map/?set=current-vaccine-intro-status&group=vaccine-introduction&category=hib
- Noni EM; The SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4164. doi:10.1016/j.vaccine.2015.04.036.
- Larson HJ, Jarrett C, Eckersberger E, Smith DMD, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine. 2014;32(19):2150–2159. doi:10.1016/j.vaccine.2014.01.081.
- Glanz K, Lewis F, Rimer BK. Health behavior and health education: theory, research, and practice; 1997 [accessed 2021 Aug 2]. https://www.med.upenn.edu/hbhe4/part2-ch3-main-constructs.shtml
- Reason JT, Manstead A, Stradling S, Baxter JS, Campbell K. Errors and violations on the roads: a real distinction? Ergonomics. 1990;33(10–11):1315–1332. doi:10.1080/00140139008925335.
- Hair JF, Babin BJ, Anderson RE, Black WC. Multivariate data analysis. London: Prentice Hall International; 1998.
- Fornell C, Larcker DF. Evaluating structural equation models with unobservable variables and management error. J Marketing Res. 1981;18(1):39–50. doi:10.2307/3151312.
- Bentler PM. Comparative fit indexes in structural models. Psychol Bull. 1990;107(2):238–246. doi:10.1037/0033-2909.107.2.238.
- Tucker L, Lewis C. A reliability coefficient for maximum likelihood factor analysis. Psychometrika. 1973;38(1):1–10. doi:10.1007/BF02291170.
- Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equation Model: A Multi J. 2009;6(1):1–55. doi:10.1080/10705519909540118.
- Steiger JH. A note on multiple sample extensions of the RMSEA fit index. Struct Equation Model: A Multi J. 1998;5(4):411–419. doi:10.1080/10705519809540115.
- Razai MS, Oakeshott P, Esmail A, Wiysonge CS, Viswanath K, Mills MC. COVID-19 vaccine hesitancy: the five Cs to tackle behavioural and sociodemographic factors. J R Soc Med. 2021;114(6):295–298. doi:10.1177/01410768211018951.
- Mueller CW, Parcel TL. Measures of socioeconomic status: alternatives and recommendations. Child Dev. 1981;52(1):13–30. doi:10.1111/1467-8624.ep8861601.
- Bandura A-S-E. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977;84(2):191–215. doi:10.1037/0033-295X.84.2.191.
- Zhang H, Garcia C, Yu W, Knoll MD, Lai X, Xu T, Jing R, Qin Y, Yin Z, Wahl B, et al. National and provincial impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in China: a modeling analysis. BMC Med. 2021;19(1):181. doi:10.1186/s12916-021-02049-7.